{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T10:08:06Z","timestamp":1774519686740,"version":"3.50.1"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Aims<\/jats:title><jats:p>The differential diagnosis between ALK-negative anaplastic large cell lymphoma (ALK<jats:sup>-<\/jats:sup> ALCL) and peripheral T-cell lymphoma, not otherwise specified (PTCL, NOS) with high expression of CD30 (CD30<jats:sup>high<\/jats:sup>) are essential. However, no reliable biomarker is available in daily practice except CD30. STAT3 is characteristically activated in ALCL. We aimed to investigate whether the status of STAT3 phosphorylation could help the differential diagnosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The status of phosphorylation of STAT3 was examined using two antibodies against pSTAT3-Y705 and pSTAT3-S727 by immunohistochemistry in ALK<jats:sup>+<\/jats:sup> ALCL (n=33), ALK<jats:sup>-<\/jats:sup> ALCL (n=22) and PTCL, NOS (n=34). Ten PTCL, NOS with diffuse CD30 expression were defined as CD30<jats:sup>high<\/jats:sup> PTCL, NOS. Flowcytometric analysis were performed to evaluate the expression of pSTAT3-Y705\/S727 in PTCL, NOS (n=3).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The median H-scores of pSTAT3-Y705 and S727 were 280 and 260 in ALK<jats:sup>+<\/jats:sup> ALCL, 250 and 240 in ALK<jats:sup>-<\/jats:sup> ALCL, and 45 and 75 in CD30<jats:sup>high<\/jats:sup> subgroup, respectively. Using H score of 145 as the cutoff value, pSTAT3-S727 alone distinguished between ALK<jats:sup>-<\/jats:sup> ALCL and CD30<jats:sup>high<\/jats:sup> PTCL, NOS with a sensitivity of 100% and specificity of 83%. Additionally, pSTAT3-S727, but not pSTAT3-Y705, was also expressed by background tumor-infiltrating lymphocytes (S727<jats:sub>TILs<\/jats:sub>) in PTCL, NOS. PTCL, NOS patients with high S727<jats:sub>TILs<\/jats:sub> H score had a favorable prognosis than those with no TILs (3-year OS rate: 43% vs. 0, <jats:italic>p<\/jats:italic>=0.013) or low S727<jats:sub>TILs<\/jats:sub> (3-year OS rate: 43% vs. 0, <jats:italic>p<\/jats:italic>=0.099). Flowcytometric analysis revealed that of the three patients investigated, two had enhanced pSTAT-S727 signals in neoplastic cell populations, and all three patients were negative for pSTAT3-Y705 expression in both tumor cells and background lymphocytes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>pSTAT3-Y705\/S727 can be used to help distinguish ALK<jats:sup>-<\/jats:sup> ALCL from CD30<jats:sup>high<\/jats:sup> PTCL, NOS and pSTAT3-S727 expression by TILs predicts the prognosis of a subset of PTCL, NOS.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2023.1132834","type":"journal-article","created":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T05:38:41Z","timestamp":1686721121000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Phosphorylated STAT3 as a potential diagnostic and predictive biomarker in ALK- ALCL vs. CD30high PTCL, NOS"],"prefix":"10.3389","volume":"14","author":[{"given":"Chenxi","family":"Xiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanna","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiting","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoli","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuiling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangzhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haipeng","family":"Si","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yubo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongshen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shimin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12030702","article-title":"The expression of the hodgkin\u2019s disease associated antigen ki-1 in reactive and neoplastic lymphoid tissue: evidence that reed-sternberg cells and histiocytic malignancies are derived from activated lymphoid cells","volume":"66","author":"Stein","year":"1985","journal-title":"Blood"},{"key":"B2","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.humpath.2005.03.004","article-title":"Differential gene expression in anaplastic lymphoma kinase-positive and anaplastic lymphoma kinase-negative anaplastic large cell lymphomas","volume":"36","author":"Thompson","year":"2005","journal-title":"Hum Pathol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/aqab012","article-title":"How I diagnose anaplastic Large cell lymphoma","volume":"155","author":"Amador","year":"2021","journal-title":"Am J Clin Pathol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the world health organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2020.05.006","article-title":"A suggested immunohistochemical algorithm for the classification of T-cell lymphomas involving lymph nodes","volume":"102","author":"Vega","year":"2020","journal-title":"Hum Pathol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.42.5611","article-title":"Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study","volume":"31","author":"Piccaluga","year":"2013","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-01-405555","article-title":"Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma","volume":"120","author":"Agnelli","year":"2012","journal-title":"Blood"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-01-134270","article-title":"ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the international peripheral T-cell lymphoma project","volume":"111","author":"Savage","year":"2008","journal-title":"Blood"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2015.03.006","article-title":"Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma","volume":"27","author":"Crescenzo","year":"2015","journal-title":"Cancer Cell"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00898","article-title":"Genomics of peripheral T-cell lymphoma and its implications for personalized medicine","volume":"10","author":"Zhang","year":"2020","journal-title":"Front Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2019.113666","article-title":"Methotrexate significantly induces apoptosis by inhibiting STAT3 activation in NPM-ALK-positive ALCL cells","volume":"170","author":"Uchihara","year":"2019","journal-title":"Biochem Pharmacol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.2741\/S436","article-title":"The role of AP-1 and epigenetics in ALCL","volume":"7","author":"Schiefer","year":"2015","journal-title":"Front Biosci (Schol Ed)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019001904","article-title":"Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL","volume":"135","author":"Laurent","year":"2020","journal-title":"Blood"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12030702","article-title":"STAT3 mutation is associated with STAT3 activation in CD30(+) ALK(-) ALCL","volume":"12","author":"Andersson","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrc2291","article-title":"The anaplastic lymphoma kinase in the pathogenesis of cancer","volume":"8","author":"Chiarle","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1038\/s41375-018-0045-9","article-title":"The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17\/ILC3 skewing of anaplastic large cell lymphoma","volume":"32","author":"Schleussner","year":"2018","journal-title":"Leukemia"},{"key":"B17","article-title":"Differential expression and clinical significance of tyrosine-phosphorylated STAT3 in ALK+ and ALK- anaplastic large cell lymphoma","volume":"9","author":"Khoury","year":"2003","journal-title":"Clin Cancer Res an Off J Am Assoc Cancer Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s41408-018-0138-8","article-title":"Prognostic and therapeutic significance of phosphorylated STAT3 and protein tyrosine phosphatase-6 in peripheral-T cell lymphoma","volume":"8","author":"Han","year":"2018","journal-title":"Blood Cancer J"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.120","article-title":"EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes","volume":"26","author":"van Dongen","year":"2012","journal-title":"Leukemia"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.941347","article-title":"Molecular subtyping of CD5+ diffuse large b-cell lymphoma based on DNA-targeted sequencing and Lymph2Cx","volume":"12","author":"Ma","year":"2022","journal-title":"Front Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V106.11.811.811","article-title":"International peripheral T-cell lymphoma (PTCL) clinical and pathologic review project: poor outcome by prognostic indices and lack of efficacy with anthracyclines","volume":"106","author":"Vose","year":"2005","journal-title":"Blood"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-09-3080","article-title":"Peripheral T-cell lymphoma unspecified (PTCL-u): a new prognostic model from a retrospective multicentric clinical study","volume":"103","author":"Gallamini","year":"2004","journal-title":"Blood"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.6327","article-title":"Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score","volume":"24","author":"Went","year":"2006","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018018754","article-title":"Microenvironmental immune cell signatures dictate clinical outcomes for PTCL-NOS","volume":"2","author":"Sugio","year":"2018","journal-title":"Blood Adv"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000779","article-title":"Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistry","volume":"134","author":"Amador","year":"2019","journal-title":"Blood"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-08-594507","article-title":"Essential role of IRF4 and MYC signaling for survival of anaplastic large cell lymphoma","volume":"125","author":"Weilemann","year":"2015","journal-title":"Blood"},{"key":"B27","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V95.6.2084","article-title":"A monoclonal antibody (MUM1p) detects expression of the MUM1\/IRF4 protein in a subset of germinal center b cells, plasma cells, and activated T cells","volume":"95","author":"Falini","year":"2000","journal-title":"Blood"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v99.9.3398","article-title":"Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma","volume":"99","author":"Jundt","year":"2002","journal-title":"Blood"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/nm1249","article-title":"Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target","volume":"11","author":"Chiarle","year":"2005","journal-title":"Nat Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1205152","article-title":"Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death","volume":"21","author":"Zamo","year":"2002","journal-title":"Oncogene"},{"key":"B31","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41375-018-0239-1","article-title":"Dependency on the TYK2\/STAT1\/MCL1 axis in anaplastic large cell lymphoma","volume":"33","author":"Prutsch","year":"2019","journal-title":"Leukemia"},{"key":"B32","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/PAS.0000000000001995","article-title":"JAK\/STAT3 signaling activation related to distinct clinicopathologic features in systemic ALK - anaplastic Large cell Lymphomas : new insights into their heterogeneity","volume":"47","author":"Wang","year":"2023","journal-title":"Am J Surg Pathol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021005171","article-title":"Peripheral T-cell lymphoma: molecular profiling recognizes subclasses and identifies prognostic markers","volume":"5","author":"Rodr\u00edguez","year":"2021","journal-title":"Blood Adv"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-16-0291","article-title":"Constitutive phosphorylation of STAT3 by the CK2-BLNK-CD5 complex","volume":"15","author":"Rozovski","year":"2017","journal-title":"Mol Cancer Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-7357-6_14","article-title":"High content imaging assays for IL-6-Induced STAT3 pathway activation in head and neck cancer cell lines","volume":"1683","author":"Johnston","year":"2018","journal-title":"Methods Mol Biol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.1038\/s41467-020-17669-5","article-title":"STAT3 serine phosphorylation is required for TLR4 metabolic reprogramming and IL-1\u03b2 expression","volume":"11","author":"Balic","year":"2020","journal-title":"Nat Commun"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1242\/dev.199477","article-title":"Y705 and S727 are required for the mitochondrial import and transcriptional activities of STAT3, and for regulation of stem cell proliferation","volume":"148","author":"Peron","year":"2021","journal-title":"Development"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2020-206868","article-title":"Expression of YAP1 and pSTAT3-S727 and their prognostic value in glioma","volume":"74","author":"Sang","year":"2021","journal-title":"J Clin Pathol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41389-019-0165-8","article-title":"The crosstalk between STAT3 and p53\/RAS signaling controls cancer cell metastasis and cisplatin resistance via the Slug\/MAPK\/PI3K\/AKT-mediated regulation of EMT and autophagy","volume":"8","author":"Liang","year":"2019","journal-title":"Oncogenesis"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2014.04.003","article-title":"Reduced phosphorylation of Stat3 at ser-727 mediated by casein kinase 2 - protein phosphatase 2A enhances Stat3 tyr-705 induced tumorigenic potential of glioma cells","volume":"26","author":"Mandal","year":"2014","journal-title":"Cell Signal"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02976-12","article-title":"Kaposi\u2019s sarcoma-associated herpesvirus kaposin b induces unique monophosphorylation of STAT3 at serine 727 and MK2-mediated inactivation of the STAT3 transcriptional repressor TRIM28","volume":"87","author":"King","year":"2013","journal-title":"J Virol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1132834\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T05:38:46Z","timestamp":1686721126000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1132834\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,14]]},"references-count":41,"alternative-id":["10.3389\/fimmu.2023.1132834"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1132834","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,14]]},"article-number":"1132834"}}